Source:http://linkedlifedata.com/resource/pubmed/id/14517961
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2003-9-30
|
pubmed:abstractText |
Diffuse leiomyomatosis is associated with the inherited kidney disease Alport syndrome, and characterized by visceral smooth muscle overgrowth within the respiratory, gastrointestinal and female reproductive tracts. Although partial deletions of the type IV collagen genes COL4A5 and COL4A6, paired head-to-head on chromosome Xq22, are known to cause diffuse leiomyomatosis, loss of function for type IV collagen does not explain smooth muscle overgrowth. To further clarify pathogenic mechanisms, we have characterized novel deletions in patients with Alport syndrome-diffuse leiomyomatosis or Alport syndrome alone. A 27.6-kb deletion, in a female with Alport syndrome-diffuse leiomyomatosis, is marked by the most proximal, i.e. most 5', COL4A5 breakpoint described to date. By comparing this deletion to others described here and previously, we have defined a minimal overlap region, only 4.2 kb in length and containing the COL4A5-COL4A6 proximal promoters, loss of which contributes to smooth muscle overgrowth. A novel deletion in a male with Alport syndrome alone is>1.4 Mb in length, encompassing COL4A5 and COL4A6 entirely, as well as neighboring genes. We postulate that loss of the 4.2-kb region in diffuse leiomyomatosis causes misregulation of neighboring genes, contributing to smooth muscle overgrowth. Deletion of the neighboring genes themselves may afford protection from this condition.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1098-1004
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2003 Wiley-Liss, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
419
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:14517961-Base Sequence,
pubmed-meshheading:14517961-Child,
pubmed-meshheading:14517961-Chromosome Mapping,
pubmed-meshheading:14517961-Chromosomes, Human, X,
pubmed-meshheading:14517961-Collagen Type IV,
pubmed-meshheading:14517961-Female,
pubmed-meshheading:14517961-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:14517961-Humans,
pubmed-meshheading:14517961-Leiomyomatosis,
pubmed-meshheading:14517961-Male,
pubmed-meshheading:14517961-Molecular Sequence Data,
pubmed-meshheading:14517961-Muscle, Smooth,
pubmed-meshheading:14517961-Nephritis, Hereditary,
pubmed-meshheading:14517961-Sequence Alignment,
pubmed-meshheading:14517961-Sequence Deletion,
pubmed-meshheading:14517961-Viscera
|
pubmed:year |
2003
|
pubmed:articleTitle |
Deletion mapping in Alport syndrome and Alport syndrome-diffuse leiomyomatosis reveals potential mechanisms of visceral smooth muscle overgrowth.
|
pubmed:affiliation |
Division of Renal Diseases and Hypertension, Department of Medicine, University of Minnesota, Minneapolis, Minnesota 55455, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|